These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12633679)

  • 1. Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats.
    Mortuza GB; Neville WA; Delaney J; Waterfield CJ; Camilleri P
    Biochim Biophys Acta; 2003 Mar; 1631(2):136-46. PubMed ID: 12633679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers to monitor drug-induced phospholipidosis.
    Baronas ET; Lee JW; Alden C; Hsieh FY
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
    Mesens N; Desmidt M; Verheyen GR; Starckx S; Damsch S; De Vries R; Verhemeldonck M; Van Gompel J; Lampo A; Lammens L
    Toxicol Pathol; 2012 Apr; 40(3):491-503. PubMed ID: 22291062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model.
    Delaney J; Neville WA; Swain A; Miles A; Leonard MS; Waterfield CJ
    Biomarkers; 2004; 9(3):271-90. PubMed ID: 15764292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipidomic identification of potential serum biomarkers in dengue fever, hepatitis B and hepatitis C using liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Khedr A; Hegazy MA; Kammoun AK; Shehata MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():44-54. PubMed ID: 26708624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a UHPLC-ESI-MS/MS method for the simultaneous quantification of mammal lysophosphatidylcholines and lysophosphatidylethanolamines in serum.
    Suárez-García S; Arola L; Pascual-Serrano A; Arola-Arnal A; Aragonès G; Bladé C; Suárez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1055-1056():86-97. PubMed ID: 28445851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats.
    Thompson KL; Zhang J; Stewart S; Rosenzweig BA; Shea K; Mans D; Colatsky T
    Toxicol Lett; 2012 Sep; 213(2):285-91. PubMed ID: 22828012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry.
    Houjou T; Yamatani K; Imagawa M; Shimizu T; Taguchi R
    Rapid Commun Mass Spectrom; 2005; 19(5):654-66. PubMed ID: 15700236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shotgun analysis of phospholipids from mouse liver and brain by nanoflow liquid chromatography/tandem mass spectrometry.
    Bang DY; Ahn Ej; Moon MH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):268-77. PubMed ID: 17296335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated strategy for establishment of metabolite profile of endogenous lysoglycerophospholipids by two LC-MS/MS platforms.
    Chen G; Song C; Jin S; Li S; Zhang Y; Huang R; Feng Y; Xu Y; Xiang Y; Jiang H
    Talanta; 2017 Jan; 162():530-539. PubMed ID: 27837867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of amiodarone and desethylamiodarone in horse plasma and urine by high-performance liquid chromatography combined with UV detection and electrospray ionization mass spectrometry.
    Maes A; Baert K; Croubels S; De Clercq D; van Loon G; Deprez P; De Backer P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):47-56. PubMed ID: 16616880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the rat.
    Thompson KL; Haskins K; Rosenzweig BA; Stewart S; Zhang J; Peters D; Knapton A; Rouse R; Mans D; Colatsky T
    Int J Toxicol; 2012; 31(1):14-24. PubMed ID: 22267869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS.
    Hasegawa M; Takenaka S; Kuwamura M; Yamate J; Tsuyama S
    Exp Toxicol Pathol; 2007 Oct; 59(2):115-20. PubMed ID: 17719757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous profiling of lysophospholipids and phospholipids from human plasma by nanoflow liquid chromatography-tandem mass spectrometry.
    Lee JY; Min HK; Moon MH
    Anal Bioanal Chem; 2011 Jul; 400(9):2953-61. PubMed ID: 21499968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of potential plasma biomarkers related to cognitive impairment by untargeted profiling of phospholipids using the HILIC-ESI-IT-TOF-MS system.
    Song S; Cheong LZ; Man QQ; Pang SJ; Li YQ; Ren B; Zhang J
    Anal Bioanal Chem; 2018 May; 410(12):2937-2948. PubMed ID: 29523943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation and quantitation of phospholipids and lysophospholipids by high-performance liquid chromatography.
    Lesnefsky EJ; Stoll MS; Minkler PE; Hoppel CL
    Anal Biochem; 2000 Oct; 285(2):246-54. PubMed ID: 11017709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ionization modifiers on the simultaneous analysis of all classes of phospholipids by nanoflow liquid chromatography/tandem mass spectrometry in negative ion mode.
    Bang DY; Lim S; Moon MH
    J Chromatogr A; 2012 Jun; 1240():69-76. PubMed ID: 22503929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS analysis of phospholipids and lysophospholipids in human bronchoalveolar lavage fluid.
    Barroso B; Bischoff R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(1):21-8. PubMed ID: 15607704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of ion pairing reagents for sensitive detection and separation of phospholipids in the positive ion mode LC-ESI-MS.
    Dodbiba E; Xu C; Payagala T; Wanigasekara E; Moon MH; Armstrong DW
    Analyst; 2011 Apr; 136(8):1586-93. PubMed ID: 21336348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.